This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
Clinical Hematology International
  • Menu
  • Articles
    • Case Report
    • Case study
    • Correspondence
    • Editorial
    • General
    • Original Research Articles
    • Perspective Article
    • Research Articles
    • Retrospective study
    • Review Articles
    • Survey
    • Systematic Reviews
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Blog
  • Conference-Event-Webinar
  • search
  • X (formerly Twitter) (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:20455/feed
ISSN 2590-0048
General
Vol. 4, Issue 3, 2022July 08, 2022 BST

The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities

Rose Ellard, Michelle Kenyon, Daphna Hutt, Erik Aerts, Maaike de Ruijter, Christian Chabannon, Mohamad Mohty, Silvia Montoto, Elisabeth Wallhult, John Murray,
CAR-TCAR-T therapyCellular therapyImmunotherapyNursingNursing education
https://doi.org/10.1007/s44228-022-00004-8
Clinical Hematology International
Ellard, Rose, Michelle Kenyon, Daphna Hutt, Erik Aerts, Maaike de Ruijter, Christian Chabannon, Mohamad Mohty, Silvia Montoto, Elisabeth Wallhult, and John Murray. 2022. “The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities.” Clinical Hematology International 4 (3): 75–88. https:/​/​doi.org/​10.1007/​s44228-022-00004-8.

View more stats

Powered by Scholastica, the modern academic journal management system